Hematopoietic/Lymphoid Cancer Completed Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0030132 (Hematopoietic/Lymphoid Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00049504Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerTreatment
NCT01982682Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical DonorTreatment